AbCellera Valuation Multiples

AbCellera Overview

About AbCellera

AbCellera Biologics Inc is an antibody discovery and development engine that’s specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company’s experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Founded

2012

HQ

Employees

596

Website

abcellera.com

Sectors

Contract Research & ManufacturingBioTech

Financials (LTM)

Revenue: $64M

EBITDA: ($209M)

EV

$793M

Valuation Multiples

Multiples.vc

Start free trial

AbCellera Financials

AbCellera reported last 12-month revenue of $64M and negative EBITDA of ($209M).

In the same LTM period, AbCellera generated $64M in gross profit, ($209M) in EBITDA losses, and had net loss of ($166M).

AbCellera P&L

In the most recent fiscal year, AbCellera reported revenue of $75M and EBITDA of ($174M).

AbCellera expects next 12-month revenue of XXX and NTM EBITDA of XXX

AbCellera Stock Performance

AbCellera has current market cap of $1B, and enterprise value of $793M.

AbCellera's stock price is $3.83.

AbCellera Valuation Multiples

AbCellera trades at 12.3x EV/Revenue multiple, and (3.8x) EV/EBITDA.

AbCellera Financial Valuation Multiples

As of March 27, 2026, AbCellera has market cap of $1B and EV of $793M.

Equity research analysts estimate AbCellera's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

AbCellera has a P/E ratio of (6.9x).

AbCellera Margins & Growth Rates

AbCellera's revenue in the last 12 month declined by (51%).

AbCellera's revenue per employee in the last FY averaged $0.1M.

AbCellera's rule of 40 is (375%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

AbCellera's rule of X is (451%) (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

AbCellera Public Comps

See public comps and valuation multiples for other Contract Research & Manufacturing comps.

AbCellera M&A Activity

AbCellera acquired XXX companies to date.

Last acquisition by AbCellera was on XXXXXXXX, XXXXX. AbCellera acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

AbCellera Investment Activity

AbCellera invested in XXX companies to date.

AbCellera made its latest investment on XXXXXXXX, XXXXX. AbCellera invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).